Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
CIDRAP

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.
MedPage Today on MSN

Trivalent mRNA flu shot more effective than standard vaccines

Randomized trial shows superiority in adults 50 and older ...
Now To Love

5 flu vaccine myths busted

“The flu vaccine cannot give you the flu because it contains inactivated virus or viral components only. Mild side effects ...
Applied Clinical Trials Online

Phase 3 Trial Finds Moderna’s mRNA-1010 Influenza Vaccine Outperformed Standard-Dose Vaccines in Adults Aged 50 Years and Older

A phase 3 trial evaluating Moderna’s investigational seasonal influenza vaccine, mRNA-1010, found the messenger RNA ...
The BMJ

Moderna’s mRNA flu vaccine outperforms standard shot, study finds

Moderna’s new mRNA based seasonal flu vaccine is more effective than traditional flu shots at preventing flu, a late stage ...

Australian children to test nasal spray flu vaccine that could replace the needle

A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems with the end game no more ...

A bird flu vaccine for humans is being trialled – here’s how it works

The first ever avian influenza vaccine recently started trials in the UK. This marks a milestone in the prevention of bird flu infections in humans. The vaccine targets the H5N1 flu strain, which ...

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of ...